SLFN11 and cancer: Studies examining predictive biomarkers for camptothecin derivatives in various cancer cell lines have identified high SLFN11 expression as a biomarker of response to DNA damaging agents, including IIQs (Marzi et al., 2019; Zoppoli et al., 2012; Barretina et al., 2012; Lok et al., 2017).